Lake Street Maintains Hold on Lifevantage, Raises Price Target to $6
Lake Street analyst Ryan Meyers maintains Lifevantage (NASDAQ:LFVN) with a Hold and raises the price target from $5 to $6.
Stocks · News reference
Lifevantage Names Terrence Moorehead As CEO
LifeVantage Corporation (NASDAQ:LFVN) ("LifeVantage" or the "Company"), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Lifevantage Q4 2026 Earnings Call Transcript
On Thursday, Lifevantage (NASDAQ:LFVN) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time access
LifeVantage Plans To Not Issue FY27 Outlook Due To Recent CEO Transition
LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced due to the recent transition in the Chief
Lifevantage Q4 Adj. EPS $0.11 Misses $0.13 Estimate, Sales $42.377M Miss $45.949M Estimate
Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.13 by 15.38 percent. This is a 35.29 percent decrease over earnings of $0.17 per share from the